leisure time -WSS

leisure time

author：knowledge 2025-10-01 14:19:27 - browse：7736

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： FDA clears AI tool for detecting skin cancer

entertainment

WSS

How digital therapeutics firms are pivoting after Pear's bankruptcy

As AI regulations shape up, health tech startups beg for clarity

Congress may force more Covid

FDA warns medical device makers about rise in fabricated data

MD Anderson's Padmanee Sharma responds to research credit suit

The tragedy of Johnson & Johnson’s Covid vaccine

leisure time

leisure time

knowledge

Sports medicine is finally prioritizing gender equality

Opioid cravings were reduced by anti

The high cost of giving birth even with insurance

Biotech venture capitalists face new demands from investors

How to save PrEP access — and even expand it

Medicare Advantage enrollment hits roughly 33.4 million

Anesthesiologist group: stop taking Ozempic before surgery

Weight loss drugs aren’t covered by Obamacare. That may change

Duchenne breakthrough therapy leaves behind pioneering families

New CMS data security rules will hurt Medicare, Medicaid research

entertainment

MD Anderson's Padmanee Sharma responds to research credit suit

FDA warns medical device makers about rise in fabricated data

The surgeon had a dilemma only a Nazi medical text could resolve

Medicare Advantage today, explained in one chart

The tragedy of Johnson & Johnson’s Covid vaccine

New CMS data security rules will hurt Medicare, Medicaid research

explore

hotspot

entertainment

hotspot